Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Rigby, Byron
Clarren, Sterling
and
Kelly, Desmond
1973.
A Psychological and Physiological Evaluation of the Effects of Intravenous Clomipramine (Anafranil).
Journal of International Medical Research,
Vol. 1,
Issue. 5,
p.
308.
Walter, C J S
1973.
Clinical Impressions on Treatment of Obsessional States with Intravenous Clomipramine (Anafranil).
Journal of International Medical Research,
Vol. 1,
Issue. 5,
p.
413.
Philpott, R.
1975.
Recent Advances in the Behavioural Measurement of Obsessional Illness Difficulties Common to These and other Measures.
Scottish Medical Journal,
Vol. 20,
Issue. 1_suppl,
p.
33.
Waxman, D.
1975.
An Investigation into the Use of Anafranil in Phobic and Obsessional Disorders.
Scottish Medical Journal,
Vol. 20,
Issue. 1_suppl,
p.
61.
Colgan, Anthony
1975.
A Pilot Study of Anafranil in the Treatment of Phobic States.
Scottish Medical Journal,
Vol. 20,
Issue. 1_suppl,
p.
55.
Souhami, R L
Ashton, C R
and
Lee-Potter, J P
1976.
Agranulocytosis and systemic candidiasis following clomipramine therapy.
Postgraduate Medical Journal,
Vol. 52,
Issue. 609,
p.
472.
Philpott, R
1976.
The assessment of drugs in obsessional states..
British Journal of Clinical Pharmacology,
Vol. 3,
Issue. S1,
p.
91.
Ananth, J.
1976.
Treatment of Obsessive Compulsive Neurosis: Pharmacological Approach.
Psychosomatics,
Vol. 17,
Issue. 4,
p.
180.
Alfredsson, Gunnel
Wiesel, Frits-Axel
Fyr�, Bengt
and
Sedvall, G�ran
1977.
Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma.
Psychopharmacology,
Vol. 52,
Issue. 1,
p.
25.
Holmberg, Gunnar
Koczkas, Sarolta
and
Wedin, Lage
1977.
Behandling av ångest och fobier med MAO-hämmare.
Nordisk Psykiatrisk Tidsskrift,
Vol. 31,
Issue. 2,
p.
97.
Trimble, Michael
1978.
Non‐Monoamine Oxidase Inhibitor Antidepressants and Epilepsy: A Review.
Epilepsia,
Vol. 19,
Issue. 3,
p.
241.
Ganguli, Rohan
and
Detre, Thomas
1981.
Future Perspectives in Behavior Therapy.
p.
83.
Kessler, Kenneth A
1981.
Drug Treatment of the Phobic-Anxiety Syndrome.
Psychiatric Annals,
Vol. 11,
Issue. 1,
p.
41.
Ananth, Jambur
Pecknold, John C.
Van Den Steen, Nancy
and
Engelsmann, Frank
1981.
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
Progress in Neuro-Psychopharmacology,
Vol. 5,
Issue. 3,
p.
257.
Pecknold, J. C.
McClure, D. J.
Appeltauer, L.
Allan, T.
and
Wrzesinski, L.
1982.
Does Tryptophan Potentiate Clomipramine in the Treatment of Agoraphobic and Social Phobic Patients?.
British Journal of Psychiatry,
Vol. 140,
Issue. 5,
p.
484.
Pöldinger, W.
and
Wider, F.
1983.
Psychopharmaka.
p.
447.
Ananth, Jambur
1983.
Clomipramine in obsessive-compulsive disorder: A review.
Psychosomatics,
Vol. 24,
Issue. 8,
p.
723.
Turner, Samuel M.
and
Michelson, Larry
1984.
Behavioral Theories and Treatment of Anxiety.
p.
239.
Ananth, Jambur
1985.
Obsessive-Compulsive Disorder.
p.
167.
Ananth, Jambur
1986.
Clomipramine: An Antiobsessive Drug.
The Canadian Journal of Psychiatry,
Vol. 31,
Issue. 3,
p.
253.
eLetters
No eLetters have been published for this article.